Overview

Leflunomide in Mild COVID-19 Patients

Status:
Recruiting
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
This study aims to examine the tolerability of high dose of leflunomide in patients with COVID-19 who are being managed in the outpatient setting.
Phase:
Phase 1
Details
Lead Sponsor:
University of Chicago
Treatments:
Leflunomide